Immediate Improvement Participants had a mean age of 63.7 years, with a greater proportion of men (64.7%) than women. The average MDS-UPDRS score was 7.4 for Part II, 24.4 for Part III, and 31.8 ...

A new therapeutic that could slow down or halt the progression of Parkinson's disease has completed Phase 1 trials with positive results. Researchers and doctors spoke about the findings.